Moreover, it was found that A2M has a moderate upregulation in almost all cancers except glioblastoma multiforme (GBM), head and neck squamous cell carcinoma (HNSC), and stomach adenocarcinoma (STAD). This evidence concerns the gene A2M and glioblastoma.